Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Clinical trial NCT05600387 · UNKNOWN

Trial details

NCT number: NCT05600387
Sponsor: Zhijun Sun
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure Heart Failure With Preserved Ejection Fraction Heart Failure With Mid Range Ejection Fraction

Start date: 2022-11-05
Primary completion: 2024-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.